Therapeutic Drug Monitoring Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology(Immunoassays, Proteomic Technologies), By Drug Class(Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, Others), By Active Ingredient (Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digitoxin, Digoxin, Disopyramide, Ethosuxamide, Gentamicin, Lidocaine, Lithium, Methotrexate, NAPA, Phenobarbital, Quinidine, Sirolimus, Tacrolimus, Vancomycin, Others), By End-User (Hospitals, Diagnostic Centres, Others), By Product (Immunoassay Equipment, Reagents, Other Consumables), By Region, Forecast & Opportunities, 2028

December 2022 | 114 pages | ID: T16CA450592EEN
TechSci Research

Abstracts

Global therapeutic drug monitoring market is expected to grow at a steady rate during the forecast period, 2024-2028. The growing need of drug profiling for various medications such as anti-epileptics, immunosuppressants, and antibiotics is the major factor for the growth of therapeutic drug monitoring market. TDM or therapeutic drug monitoring is the primary diagnostic tool that is used to deliver an optimized dose of the drugs to define drug concentration range in blood or plasma. Therapeutic drug monitoring applications include the diagnosis of toxicity and identification and subsequent tailoring of optimal drug dose. Therapeutic drug monitoring also helps in diagnosing the cause of failed therapy outcomes and it can refine patient care by adjusting the drug dosage for better outcomes. The other factors supporting the growth of the therapeutic drug monitoring market include increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring market and rise in drug profiling. Besides, the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies are expected to augment the growth of the market.

The global therapeutic drug monitoring market is segmented into technology, drug class, active ingredient, end user, product, company and region. Based on technology, immunoassays are expected to be the dominant segment in the forecast period. Immunoassays are easy to perform and do not require specialized training. Based on drug class, antiepileptic drugs are expected to be the dominant segment in the forecast period. These are most frequently monitored class of drugs due to their narrow therapeutic range and challenging pharmacokinetics.

Regionally, North America is expected to dominate the market in the forecast period. High rate of organ transplantation and gradual adoption of metabolite measuring procedures is the major driving factor for the growth of TDM market in the region. Asia Pacific is the second largest region which is expected to dominate the market share in the forecast period. The continuous efforts of government to provide low-cost services with the aim of promoting dosage patterns is the driving factor for growth of TDM market in Asia Pacific.

Major players operating in the global therapeutic drug monitoring market include Biognosys AG, Siemens Healthineers Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., B?HLMANN Laboratories AG, Laboratory Corporation of America® Holdings, Randox Laboratories Limited, and Sekisui Medical Co.

Objective of the Study:

• To analyze and estimate the market size of global therapeutic drug monitoring market from 2018 to 2021.
• To estimate and forecast the market size of global therapeutic drug monitoring market from 2022 to 2028 and growth rate until 2028.
• To classify and forecast global therapeutic drug monitoring market based on technology, drug class, active ingredient, end-user, product, company and regional distribution.
• To identify dominant region or segment in the global therapeutic drug monitoring market.
• To identify drivers and challenges for global therapeutic drug monitoring market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic drug monitoring market.
• To identify and analyze the profile of leading players operating in global therapeutic drug monitoring market.
• To identify key sustainable strategies adopted by market players in global therapeutic drug monitoring market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic drug monitoring market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Therapeutic drug monitoring manufacturers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to therapeutic drug monitoring
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global therapeutic drug monitoring market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Therapeutic Drug Monitoring Market, By Technology:
• Immunoassays
• Proteomic Technologies
• Global Therapeutic Drug Monitoring Market, By Drug Class:
• Antiarrhythmic Drugs
• Immunosuppressants
• Antiepileptic Drugs
• Others
• Global Therapeutic Drug Monitoring Market, By Active Ingredient:
• Amikacin
• Caffeine
• Carbamazepine
• Cyclosporine
• Digitoxin
• Digoxin
• Disopyramide
• Ethosuxamide
• Gentamicin
• Lidocaine
• Lithium
• Mithotrexate
• NAPA
• Phenobarbital
• Quinidine
• Sirolimus
• Tacrolimus
• Vancomycin
• Others
• Global Therapeutic Drug Monitoring Market, By End User:
• Hospitals
• Diagnostic Centers
• Others
• Global Therapeutic Drug Monitoring Market, By Product:
• Immunoassay Equipment
• Reagents
• Other Consumables
• Global Therapeutic Drug Monitoring Market, By Region:
• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• India
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Europe
• Germany
• France
• United Kingdom
• Italy

Spain

• Middle East & Africa
• South Africa
• Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global therapeutic drug monitoring market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Technology (Immunoassays, Proteomic Technologies)
  5.2.2. By Drug Class (Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, Others)
    5.2.2.1. By Active Ingredient (Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digitoxin, Digoxin, Disopyramide, Ethosuxamide, Gentamicin, Lidocaine, Lithium, Methotrexate, NAPA, Phenobarbital, Quinidine, Sirolimus, Tacrolimus, Vancomycin, Others)
  5.2.3. By Product (Immunoassay Equipment, Reagents, Other Consumables)
  5.2.4. By End-User (Hospitals, Diagnostic Centres, Others)
  5.2.5. By Company (2022)
  5.2.6. By Region
5.3. Product Market Map

6. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Technology
  6.2.2. By Drug Class
  6.2.3. By Product
  6.2.4. By End-User
  6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
  6.3.1. China Therapeutic Drug Monitoring Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Technology
      6.3.1.2.2. By Drug Class
      6.3.1.2.3. By Product
      6.3.1.2.4. By End-User
  6.3.2. India Therapeutic Drug Monitoring Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Technology
      6.3.2.2.2. By Drug Class
      6.3.2.2.3. By Product
      6.3.2.2.4. By End-User
  6.3.3. Japan Therapeutic Drug Monitoring Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Technology
      6.3.3.2.2. By Drug Class
      6.3.3.2.3. By Product
      6.3.3.2.4. By End-User
  6.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
    6.3.4.1. Market Size & Forecast
      6.3.4.1.1. By Value
    6.3.4.2. Market Share & Forecast
      6.3.4.2.1. By Technology
      6.3.4.2.2. By Drug Class
      6.3.4.2.3. By Product
      6.3.4.2.4. By End-User

7. EUROPE THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Technology
  7.2.2. By Drug Class
  7.2.3. By End-User
  7.2.4. By Product
  7.2.5. By Country
7.3. Europe: Country Analysis
  7.3.1. France Therapeutic Drug Monitoring Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Technology
      7.3.1.2.2. By Drug Class
      7.3.1.2.3. By Product
      7.3.1.2.4. By End-User
  7.3.2. Germany Therapeutic Drug Monitoring Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Technology
      7.3.2.2.2. By Drug Class
      7.3.2.2.3. By Product
      7.3.2.2.4. By End-User
  7.3.3. United Kingdom Therapeutic Drug Monitoring Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Technology
      7.3.3.2.2. By Drug Class
      7.3.3.2.3. By Product
      7.3.3.2.4. By End-User
  7.3.4. Italy Therapeutic Drug Monitoring Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Technology
      7.3.4.2.2. By Drug Class
      7.3.4.2.3. By Product
      7.3.4.2.4. By End-User
  7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Technology
      7.3.5.2.2. By Drug Class
      7.3.5.2.3. By Product
      7.3.5.2.4. By End-User

8. NORTH AMERICA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Technology
  8.2.2. By Drug Class
  8.2.3. By Product
  8.2.4. By End-User
  8.2.5. By Country
8.3. North America: Country Analysis
  8.3.1. United States Therapeutic Drug Monitoring Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Technology
      8.3.1.2.2. By Drug Class
      8.3.1.2.3. By Product
      8.3.1.2.4. By End-User
  8.3.2. Mexico Therapeutic Drug Monitoring Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Technology
      8.3.2.2.2. By Drug Class
      8.3.2.2.3. By Product
      8.3.2.2.4. By End-User
  8.3.3. Canada Therapeutic Drug Monitoring Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Technology
      8.3.3.2.2. By Drug Class
      8.3.3.2.3. By Product
      8.3.3.2.4. By End-User

9. SOUTH AMERICA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Technology
  9.2.2. By Drug Class
  9.2.3. By Product
  9.2.4. By End-User
  9.2.5. By Country
9.3. South America: Country Analysis
  9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Technology
      9.3.1.2.2. By Drug Class
      9.3.1.2.3. By Product
      9.3.1.2.4. By End-User
  9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Technology
      9.3.2.2.2. By Drug Class
      9.3.2.2.3. By Product
      9.3.2.2.4. By End-User
  9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Technology
      9.3.3.2.2. By Drug Class
      9.3.3.2.3. By Product
      9.3.3.2.4. By End-User

10. MIDDLE EAST AND AFRICA THERAPEUTIC DRUG MONITORING MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Technology
  10.2.2. By Drug Class
  10.2.3. By Product
  10.2.4. By End-User
  10.2.5. By Country
10.3. MEA: Country Analysis
  10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Technology
      10.3.1.2.2. By Drug Class
      10.3.1.2.3. By Product
      10.3.1.2.4. By End-User
  10.3.2. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Technology
      10.3.2.2.2. By Drug Class
      10.3.2.2.3. By Product
      10.3.2.2.4. By End-User
  10.3.3. UAE Therapeutic Drug Monitoring Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Technology
      10.3.3.2.2. By Drug Class
      10.3.3.2.3. By Product
      10.3.3.2.4. By End-User
  10.3.4. Israel Therapeutic Drug Monitoring Market Outlook
    10.3.4.1. Market Size & Forecast
      10.3.4.1.1. By Value
    10.3.4.2. Market Share & Forecast
      10.3.4.2.1. By Technology
      10.3.4.2.2. By Drug Class
      10.3.4.2.3. By Product
      10.3.4.2.4. By End-User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

13. COMPETITIVE LANDSCAPE

13.1. Biognosys AG
13.2. Siemens Healthineers Inc.
13.3. Bio-Rad Laboratories, Inc.
13.4. Danaher Corporation
13.5. Thermo Fisher Scientific Inc.
13.6. F Hoffmann-La Roche Ltd.
13.7. B?HLMANN Laboratories AG
13.8. Laboratory Corporation of America® Holdings
13.9. Randox Laboratories Limited
13.10. Sekisui Medical Co

14. STRATEGIC RECOMMENDATIONS